PainReform (PRFX) Projected to Post Earnings on Monday

PainReform (NASDAQ:PRFX) is projected to release its earnings data before the market opens on Monday, March 17th. Analysts expect PainReform to post earnings of ($4.74) per share for the quarter.

PainReform Trading Up 5.1 %

NASDAQ PRFX traded up $0.14 on Friday, reaching $2.79. 54,886 shares of the stock were exchanged, compared to its average volume of 1,097,558. PainReform has a one year low of $1.73 and a one year high of $61.20. The firm has a market capitalization of $2.44 million, a PE ratio of -0.02 and a beta of 0.61. The company’s 50-day simple moving average is $3.11 and its two-hundred day simple moving average is $2.94.

About PainReform

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.